{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T01:10:02Z","timestamp":1749949802668,"version":"3.41.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","award":["R01 HL132985","R01 HL136373"],"award-info":[{"award-number":["R01 HL132985","R01 HL136373"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jacl.2025.04.196","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T18:46:07Z","timestamp":1746729967000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterization of familial chylomicronemia syndrome in a compound heterozygote for 2 APOA5 nonsense variants"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9315-0152","authenticated-orcid":false,"given":"Paul A.","family":"Mueller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Rosario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7377-1269","authenticated-orcid":false,"given":"Joshua","family":"Hay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3855-3498","authenticated-orcid":false,"given":"Paige","family":"Bergstrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6772-6389","authenticated-orcid":false,"given":"Silvia Cecilia","family":"Pacheco-Vel\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2861-5325","authenticated-orcid":false,"given":"Robert A.","family":"Hegele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Pamir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan Q.","family":"Purnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2025.04.196_bib0001","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3389\/fendo.2020.00616","article-title":"Hypertriglyceridemia-causes, significance, and approaches to therapy","volume":"11","author":"Santos-Baez","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jacl.2025.04.196_bib0002","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3389\/fendo.2020.00252","article-title":"Causes and consequences of hypertriglyceridemia","volume":"11","author":"Packard","year":"2020","journal-title":"Front Endocrinol"},{"issue":"12","key":"10.1016\/j.jacl.2025.04.196_bib0003","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1210\/js.2019-00214","article-title":"Differentiating familial chylomicronemia syndrome from multifactorial severe hypertriglyceridemia by clinical profiles","volume":"3","author":"O'Dea","year":"2019","journal-title":"J Endocr Soc"},{"issue":"4","key":"10.1016\/j.jacl.2025.04.196_bib0004","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/joim.13016","article-title":"Familial chylomicronemia syndrome: an under-recognized cause of severe hypertriglyceridaemia","volume":"287","author":"Baass","year":"2020","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.jacl.2025.04.196_bib0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12944-022-01631-z","article-title":"Causes, clinical findings and therapeutic options in chylomicronemia syndrome, a special form of hypertriglyceridemia","volume":"21","author":"Paragh","year":"2022","journal-title":"Lipids Health Dis"},{"issue":"6","key":"10.1016\/j.jacl.2025.04.196_bib0006","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrendo.2015.26","article-title":"Chylomicronaemia\u2014Current diagnosis and future therapies","volume":"11","author":"Brahm","year":"2015","journal-title":"Nature Rev Endocrinol"},{"issue":"2","key":"10.1016\/j.jacl.2025.04.196_bib0007","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2796.2012.02516.x","article-title":"Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia","volume":"272","author":"Surendran","year":"2012","journal-title":"J Intern Med"},{"issue":"3","key":"10.1016\/j.jacl.2025.04.196_bib0008","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MOL.0b013e32833854c0","article-title":"Lipase maturation factor 1: structure and role in lipase folding and assembly","volume":"21","author":"Doolittle","year":"2010","journal-title":"Curr Opin Lipidol"},{"issue":"5","key":"10.1016\/j.jacl.2025.04.196_bib0009","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1101\/gad.209296.112","article-title":"Biochemistry and pathophysiology of intravascular and intracellular lipolysis","volume":"27","author":"Young","year":"2013","journal-title":"Genes Dev"},{"key":"10.1016\/j.jacl.2025.04.196_bib0010","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fendo.2020.00455","article-title":"Genetics of hypertriglyceridemia","volume":"11","author":"Dron","year":"2020","journal-title":"Front Endocrinol (Lausanne)."},{"key":"10.1016\/j.jacl.2025.04.196_bib0011","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.atherosclerosis.2017.10.025","article-title":"Apolipoprotein C-II: new findings related to genetics, biochemistry, and role in triglyceride metabolism","volume":"267","author":"Wolska","year":"2017","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.jacl.2025.04.196_bib0012","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.jacl.2018.05.014","article-title":"Co-occurrence of heterozygous CREB3L3 and APOA5 nonsense variants and polygenic risk in a patient with severe hypertriglyceridemia exacerbated by estrogen administration","volume":"12","author":"W\u00f3jcik","year":"2018","journal-title":"J Clin Lipidol"},{"issue":"2","key":"10.1016\/j.jacl.2025.04.196_bib0013","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41588-020-00757-z","article-title":"Genetics of 35 blood and urine biomarkers in the UK Biobank","volume":"53","author":"Sinnott-Armstrong","year":"2021","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.jacl.2025.04.196_bib0014","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1172\/JCI24471","article-title":"Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment","volume":"115","author":"Mar\u00e7ais","year":"2005","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.jacl.2025.04.196_bib0015","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1073\/pnas.1909378117","article-title":"Precision medicine integrating whole-genome sequencing, comprehensive metabolomics, and advanced imaging","volume":"117","author":"Hou","year":"2020","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"10.1016\/j.jacl.2025.04.196_bib0016","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12920-020-0669-2","article-title":"Six years' experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias","volume":"13","author":"Dron","year":"2020","journal-title":"BMC Med Genomics"},{"issue":"Pt 4","key":"10.1016\/j.jacl.2025.04.196_bib0017","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/0004563214525767","article-title":"Clinical features and genetic analysis of three patients with severe hypertriglyceridaemia","volume":"51","author":"Hooper","year":"2014","journal-title":"Ann Clin Biochem"},{"issue":"18","key":"10.1016\/j.jacl.2025.04.196_bib0018","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2025167118","article-title":"Divergent low-density lipoprotein receptor (LDLR) linked to low VSV G-dependent viral infectivity and unique serum lipid profile in zebra finches","volume":"118","author":"Velho","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.jacl.2025.04.196_bib0019","doi-asserted-by":"crossref","first-page":"9138","DOI":"10.1038\/s41598-022-13040-4","article-title":"A method for lipoprotein (a) isolation from a small volume of plasma with applications for clinical research","volume":"12","author":"Mueller","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jacl.2025.04.196_bib0020","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13024-016-0069-4","article-title":"A rapid and cost-effective method for genotyping apolipoprotein E gene polymorphism","volume":"11","author":"Zhong","year":"2016","journal-title":"Mol Neurodegeneration"},{"issue":"4","key":"10.1016\/j.jacl.2025.04.196_bib0021","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1194\/jlr.D045963","article-title":"LipidSeq: a next-generation clinical resequencing panel for monogenic dyslipidemias","volume":"55","author":"Johansen","year":"2014","journal-title":"J Lipid Res"},{"issue":"W1","key":"10.1016\/j.jacl.2025.04.196_bib0022","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.jacl.2025.04.196_bib0023","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1093\/bioinformatics\/btz828","article-title":"QMEANDisCo-distance constraints applied on model quality estimation","volume":"36","author":"Studer","year":"2020","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.jacl.2025.04.196_bib0024","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-09654-8","article-title":"Modeling protein quaternary structure of homo- and hetero-oligomers beyond binary interactions by homology","volume":"7","author":"Bertoni","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacl.2025.04.196_bib0025","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0076-6879(94)33053-0","article-title":"Rapid isolation of lipoproteins and assessment of their peroxidation by high-performance liquid chromatography postcolumn chemiluminescence","volume":"233","author":"Sattler","year":"1994","journal-title":"Methods Enzymol"},{"issue":"10","key":"10.1016\/j.jacl.2025.04.196_bib0026","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1161\/CIRCRESAHA.120.316526","article-title":"High-density lipoprotein carries markers that track with recovery from stroke","volume":"127","author":"Plubell","year":"2020","journal-title":"Circ Res"},{"issue":"15","key":"10.1016\/j.jacl.2025.04.196_bib0027","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92176","article-title":"Plasminogen promotes cholesterol efflux by the ABCA1 pathway","volume":"2","author":"Pamir","year":"2017","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.jacl.2025.04.196_bib0028","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1194\/jlr.M090555","article-title":"Genetic control of the mouse HDL proteome defines HDL traits, function, and heterogeneity","volume":"60","author":"Pamir","year":"2019","journal-title":"J Lipid Res"},{"issue":"10","key":"10.1016\/j.jacl.2025.04.196_bib0029","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1161\/CIRCRESAHA.120.316526","article-title":"High-density lipoprotein carries markers that track with recovery from stroke","volume":"127","author":"Plubell","year":"2020","journal-title":"Circulation research"},{"issue":"7","key":"10.1016\/j.jacl.2025.04.196_bib0030","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1194\/jlr.M300078-JLR200","article-title":"ABCA1 redistributes membrane cholesterol independent of apolipoprotein interactions","volume":"44","author":"Vaughan","year":"2003","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.jacl.2025.04.196_bib0031","doi-asserted-by":"crossref","first-page":"9138","DOI":"10.1038\/s41598-022-13040-4","article-title":"A method for lipoprotein (a) isolation from a small volume of plasma with applications for clinical research","volume":"12","author":"Mueller","year":"2022","journal-title":"Scientific Reports"},{"issue":"4","key":"10.1016\/j.jacl.2025.04.196_bib0032","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.tjnut.2024.01.007","article-title":"Fish oil supplementation modifies the proteome, lipidome, and function of high-density lipoprotein: Findings from a trial in young healthy adults","volume":"154","author":"Mueller","year":"2024","journal-title":"J Nutr"},{"issue":"1","key":"10.1016\/j.jacl.2025.04.196_bib0033","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jacl.2018.10.006","article-title":"Severe hypertriglyceridemia is primarily polygenic","volume":"13","author":"Dron","year":"2019","journal-title":"J Clin Lipidol"},{"issue":"5","key":"10.1016\/j.jacl.2025.04.196_bib0034","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"7809","key":"10.1016\/j.jacl.2025.04.196_bib0035","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jacl.2025.04.196_bib0036","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bbrc.2010.09.084","article-title":"Effect in vitro of apolipoprotein A-V on the structure and functions of recombinant high density lipoprotein","volume":"401","author":"Zhang","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"issue":"D1","key":"10.1016\/j.jacl.2025.04.196_bib0037","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/j.jacl.2025.04.196_bib0038","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/0004563214525767","article-title":"Clinical features and genetic analysis of three patients with severe hypertriglyceridaemia","volume":"51","author":"Hooper","year":"2014","journal-title":"Ann Clin Biochem"},{"issue":"2","key":"10.1016\/j.jacl.2025.04.196_bib0039","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.atherosclerosis.2011.09.030","article-title":"Resequencing the apolipoprotein A5 (APOA5) gene in patients with various forms of hypertriglyceridemia","volume":"219","author":"Evans","year":"2011","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.jacl.2025.04.196_bib0040","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.bbalip.2011.12.002","article-title":"Apolipoprotein A-V dependent modulation of plasma triacylglycerol: a puzzlement","volume":"1821","author":"Sharma","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"21","key":"10.1016\/j.jacl.2025.04.196_bib0041","doi-asserted-by":"crossref","first-page":"15484","DOI":"10.1074\/jbc.M611797200","article-title":"The C terminus of apolipoprotein A-V modulates lipid-binding activity","volume":"282","author":"Beckstead","year":"2007","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.jacl.2025.04.196_bib0042","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1161\/ATVBAHA.110.210815","article-title":"Intravenous injection of apolipoprotein A-V reconstituted high-density lipoprotein decreases hypertriglyceridemia in apoav-\/- mice and requires glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1","volume":"30","author":"Shu","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"10.1016\/j.jacl.2025.04.196_bib0043","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1194\/jlr.C070946","article-title":"Multidimensional regulation of lipoprotein lipase: impact on biochemical and cardiovascular phenotypes","volume":"57","author":"Hegele","year":"2016","journal-title":"J Lipid Res"},{"issue":"10","key":"10.1016\/j.jacl.2025.04.196_bib0044","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1161\/ATVBAHA.108.172866","article-title":"Effects of six APOA5Variants, identified in patients with severe hypertriglyceridemia, on In vitro lipoprotein lipase activity and receptor binding","volume":"28","author":"Dorfmeister","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"10.1016\/j.jacl.2025.04.196_bib0045","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1161\/01.ATV.0000186189.26141.12","article-title":"Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants","volume":"25","author":"Grosskopf","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.jacl.2025.04.196_bib0046","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1515\/hsz-2011-0259","article-title":"Apolipoprotein A5 internalized by human adipocytes modulates cellular triglyceride content","volume":"393","author":"Zheng","year":"2012","journal-title":"Biol Chem"},{"issue":"5540","key":"10.1016\/j.jacl.2025.04.196_bib0047","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1126\/science.1064852","article-title":"An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing","volume":"294","author":"Pennacchio","year":"2001","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.jacl.2025.04.196_bib0048","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1194\/jlr.M071126","article-title":"Aromatic residues in the C terminus of apolipoprotein C-III mediate lipid binding and LPL inhibition","volume":"58","author":"Meyers","year":"2017","journal-title":"J Lipid Res"},{"issue":"9","key":"10.1016\/j.jacl.2025.04.196_bib0049","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1194\/jlr.M078220","article-title":"Apolipoprotein C-III inhibits triglyceride hydrolysis by GPIHBP1-bound LPL","volume":"58","author":"Larsson","year":"2017","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.jacl.2025.04.196_bib0050","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1194\/jlr.D071787","article-title":"Lipoprotein lipase activity and interactions studied in human plasma by isothermal titration calorimetry","volume":"58","author":"Reimund","year":"2017","journal-title":"J Lipid Res"},{"issue":"3","key":"10.1016\/j.jacl.2025.04.196_bib0051","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1172\/JCI26206","article-title":"Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL","volume":"117","author":"Vaisar","year":"2007","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.jacl.2025.04.196_bib0052","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1388-1981(99)00077-3","article-title":"Phospholipid transfer protein enhances removal of cellular cholesterol and phospholipids by high-density lipoprotein apolipoproteins","volume":"1439","author":"Wolfbauer","year":"1999","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.jacl.2025.04.196_bib0053","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.amjmed.2007.10.004","article-title":"Chylomicronemia and the Chylomicronemia syndrome: a practical approach to management","volume":"121","author":"Leaf","year":"2008","journal-title":"Am J Med"},{"issue":"11","key":"10.1016\/j.jacl.2025.04.196_bib0054","first-page":"1078","article-title":"The effect of a fat-restricted diet in four patients with familial chylomicronemia syndrome: a long-term follow-up study","volume":"8","author":"Thajer","year":"2021","journal-title":"Children (Basel)"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425002727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425002727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:42:17Z","timestamp":1749948137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287425002727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":54,"alternative-id":["S1933287425002727"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2025.04.196","relation":{},"ISSN":["1933-2874"],"issn-type":[{"type":"print","value":"1933-2874"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of familial chylomicronemia syndrome in a compound heterozygote for 2 APOA5 nonsense variants","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2025.04.196","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 National Lipid Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}